Phreesia Inc(PHR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 27 at 5:36 PM ET (Korea 10/28 06:36)
Full metrics table
| Index | RUT | P/E | 72.76 | EPS (ttm) | 0.17 | Insider Own | 8.47% | Shs Outstand | 62.0M | Perf Week | 1.99% |
| Market Cap | 0.76B | Forward P/E | 18.62 | EPS next Y | 124.62% | Insider Trans | -0.24% | Shs Float | 56.8M | Perf Month | 21.68% |
| Enterprise Value | 0.76B | PEG | 0.11 | EPS next Q | 0.12 | Inst Own | 94.44% | Short Float | 5.42% | Perf Quarter | 10.32% |
| Income | 0.01B | P/S | 1.5 | EPS this Y | 634.57% | Inst Trans | -0.14% | Short Ratio | 4.14 | Perf Half Y | 30.47% |
| Sales | 0.51B | P/B | 2.05 | EPS next 5Y | 165.29% | ROA | 1.98% | Short Interest | 3.08M | Perf YTD | -27.36% |
| Book/sh | 5.99 | P/C | 10.46 | EPS past 3/5Y | - | ROE | 3.12% | 52W High | -48.5% ($23.87) | Perf Year | -47.64% |
| Cash/sh | 1.18 | P/FCF | 10.13 | Sales past 3/5Y | 19.6% 26.45% | ROIC | 2.41% | 52W Low | 58.17% ($7.77) | Perf 3Y | -1.29% |
| Dividend Est. | - | EV/EBITDA | 12.03 | EPS Y/Y TTM | 141.6% | Gross Margin | 60.12% | Volatility(W/M) | 3.79% 3.9% | Perf 5Y | -81.5% |
| Dividend TTM | - | EV/Sales | 1.49 | Sales Y/Y TTM | 12.93% | Oper. Margin | 5.01% | ATR (14) | 0.44 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.76 | EPS Q/Q | 189.62% | Profit Margin | 2.06% | RSI (14) | 66.54 | Recom | 1.89 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.76 | Sales Q/Q | 10.41% | SMA20 | 10.01% ($11.17) | Beta | 0.77 | Target Price | $13.93 |
| Payout | - | Debt/Eq | 0.18 | Earnings | 2026/9/2 | SMA50 | 11.69% ($11) | Rel Volume | 0.87 | Prev Close | $12.61 |
| Employees | 1789 | LT Debt/Eq | 0.17 | EPS/Sales Surpr. | -64.75% 0.31% | SMA200 | 11.86% ($10.99) | Avg Volume(3M) | 0.74M | Price | $12.29 |
| IPO | 2019/7/18 | Option/Short | Yes/Yes | Trades | 4051 | Volume | 646,905 | Change | -2.54% |
🏥 Phreesia (ticker: PHR) is a U.S. healthcare information technology platform company that digitizes patient intake, billing, and engagement for medical providers. It automates administrative workflows such as appointment scheduling, pre-visit questionnaires, insurance verification, and patient payments, helping hospitals and clinics improve operational efficiency. By combining subscription fees, payment transaction fees, and data- and analytics-driven value-added services, the company has continued to deliver rapid revenue growth.
Over the past 1 year, roughly in the middle
49% below its 1-year high.
Traded about as much as usual. That is 87% of its average volume.
PHR earns at a steady pace
Of every $100 in sales, $5.01 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +634.6% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $1,862. Peers typically go for $2,134.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -81.5%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 94.4%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #17 of 41 in the industry
Based on market cap of $763M.
FAQ
What kind of company is PHR?
PHR belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of PHR?
The market cap of PHR is approximately $763M, ranking 2,796 within its sector.
What is the P/E ratio of PHR?
PHR has a P/E ratio of approximately 72.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for PHR?
PHR has recorded a 52-week high of $23.87 and a low of $7.77.
